Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
British Journal of Haematology|August 1, 2024
Targeting the redox vulnerability of acute myeloid leukaemia cells with a combination of auranofin and vitamin CZhiliang Hei, Shujun Yang, Guifang Ouyang, et al.
Transplantation and Cellular Therapy|August 3, 2025
NUP98 Rearrangement Dynamics Predict Outcomes in Adult Patients With Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Real-World StudyXiaolin Yuan, Lihong Ni, Ting Chen, et al.
Frontiers in Immunology|March 9, 2023
The gut microbiota correlate with the disease characteristics and immune status of patients with untreated diffuse large B-cell lymphomaZhouning Lin, Dan Mao, Changyu Jin, et al.
Bone Marrow Transplantation|January 9, 2026
Validation of risk stratification and novel prognostic biomarkers in asian adult HSCT recipients with TA-TMA: A multicenter real-world studyYibo Wu, Xiaolin Yuan, Lieguang Chen, et al.
Hematology (Amsterdam, Netherlands)|December 1, 2023
Clinical characteristics and outcomes of COVID-19 infection in Chinese patients with hematologic malignancies in the Omicron eraXian Li, Aiqi Zhao, Huifang Jiang, et al.
Cancer|February 5, 2024
Comparison of long-term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia-positive acute lymphoblastic leukemia: A multicenter retrospective studyFangshu Guan, Luxin Yang, Yi Chen, et al.
Frontiers in Immunology|May 26, 2023
Minimal residual disease status improved the response evaluation in patients with Waldenström's macroglobulinemiaWenjie Xiong, Zanzan Wang, Tingyu Wang, et al.
Bone Marrow Transplantation|November 1, 2023
Prophylactic versus Preemptive modified donor lymphocyte infusion for high-risk acute leukemia after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective studyLuxin Yang, Xiaoyu Lai, Ting Yang, et al.
Haematologica|November 20, 2025
Decitabine plus all-trans retinoic acid versus decitabine monotherapy for myelodysplastic syndromes with excess blasts: a multicenter, randomized controlled trialXinping Zhou, Yanjuan Lin, Yan Gao, et al.
Frontiers in Immunology|August 28, 2020
Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell TransplantationLixia Sheng, Qitian Mu, Xiaoqing Wu, et al.
Pageof 11